AbbVie Valuation

AbbVie Inc -- USA Stock  

USD 93.6  0.87  0.92%

AbbVie Inc shows prevailing Real Value of $86.6941 per share. The current price of the firm is $93.6. At this time the firm appears to be over valued. Macroaxis approximates value of AbbVie Inc from analyzing the firm fundamentals such as Profit Margin of 24.77% and Return On Equity of 113.57% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.

Valuation Drivers Correlation

Selected AbbVie Inc Valuation Data Over Time

Net Income Per Employee    Enterprise Value    Market Capitalization    
Investment Horizon     30 Days    Login   to change
AbbVie Inc is number one stock in price to book category among related companies. It is rated second in beta category among related companies totaling about  0.06  of Beta per Price to Book. The ratio of Price to Book to Beta for AbbVie Inc is roughly  17.49 
Over Valued
November 23, 2017
Market Value
Downside upside
Real Value
Target Price Odds
 Above  Below  
Upside upside
AbbVie is not too risky asset. Calculation of real value of AbbVie Inc is based on 1 month time horizon. Increasing AbbVie Inc time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.


AbbVie Analyst Recommendations
Target PriceAdvice# of Analysts
AbbVie Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
AbbVie Analyst Advice  

Tax Efficiency

AbbVie Inc Tax Efficiency History

Tax Efficiency

Market Capitalization

AbbVie Market Capitalization Analysis
AbbVie Inc is number one stock in market capitalization category among related companies. Market capitalization of Pharmaceuticals And Biosciences industry is presently estimated at about 350.13 Billion. AbbVie totals roughly 149.44 Billion in market capitalization claiming about 43% of equities listed under Pharmaceuticals And Biosciences industry.
Capitalization  Workforce  Total debt  Revenue  Valuation


AbbVie Inc Revenue
Based on latest financial disclosure AbbVie Inc reported 26.71 B of revenue. This is 310.93% higher than that of the Healthcare sector, and significantly higher than that of Pharmaceuticals And Biosciences industry, The Revenue for all stocks is 171.26% lower than the firm.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.